Trombodipine
Trombodipine is a hypothetical pharmaceutical compound that is primarily used as an antithrombotic agent. It is designed to prevent the formation of blood clots by inhibiting platelet aggregation. This article provides a comprehensive overview of Trombodipine, including its mechanism of action, clinical uses, pharmacokinetics, side effects, and contraindications.
Mechanism of Action[edit | edit source]
Trombodipine functions by selectively inhibiting the platelet activation pathway. It targets the P2Y12 receptor, a key receptor involved in the amplification of platelet aggregation. By blocking this receptor, Trombodipine effectively reduces the ability of platelets to clump together, thereby decreasing the risk of thrombus formation.
Clinical Uses[edit | edit source]
Trombodipine is indicated for the prevention of myocardial infarction, stroke, and other conditions associated with increased risk of thromboembolic events. It is often prescribed to patients with a history of acute coronary syndrome or those undergoing percutaneous coronary intervention (PCI).
Pharmacokinetics[edit | edit source]
Trombodipine is administered orally and is rapidly absorbed in the gastrointestinal tract. It has a bioavailability of approximately 80%. The drug is extensively metabolized in the liver, primarily by the cytochrome P450 enzyme system. The elimination half-life of Trombodipine is approximately 8 hours, and it is excreted mainly via the renal route.
Side Effects[edit | edit source]
Common side effects of Trombodipine include bleeding, bruising, and gastrointestinal disturbances. Rare but serious side effects may include thrombocytopenia and allergic reactions.
Contraindications[edit | edit source]
Trombodipine is contraindicated in patients with active bleeding disorders, severe liver impairment, or known hypersensitivity to the drug. Caution is advised when prescribing Trombodipine to patients with a history of peptic ulcer disease or those taking other anticoagulant medications.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
